Master in Psychopharmacology and Illicit Drugs, Master in Public Health & Master in International Relations
Psychopharmacologist & researcher specialised in harm reduction, psychedelics and other drugs , Energy Control (ABD) , SCANNER Project
Psychopharmacologist, researcher, writer and scientific advisor specialized in harm reduction, psychedelics, nootropics and other psychoactive drugs. Master in Psychopharmacology and Illicit Drugs, Master in Public Health & Master in International Relations. Works as project manager in information, harm reduction & drug checking NGOs & programs like Energy Control (ABD) and is scientific advisor for several institutions. Author of the book "Essential guide to the psychedelic renaissance" he is co-founder of Madrid's Psychedelic Society and the spanish SEMPsi, member of the European psychedelic science association MIND, the Commission on International Drug Policy of the UNAD network and was a trainee at the EU Drugs Agency at Lisbon.
The influence of legislation on the availability of NPS: Monitoring the impact in darknet cryptomarkets
The most common way tackling the appearance of new psychoactive substances (NPS) has been legislative change. But, how does these legislative changes for NPS affect its availability in the darknet markets? What is happening with 3-MMC in the darknet after the legislative changes in NL? This research, continuation of the EU-wide SCANNER project, keeps answering this question by following the availability of different NPSs in three major darknet cryptomarkets in 2022. Using a prospective method, monthly datapoints and a new script developed to automatically extract information on different variables associated with the availability and demand of these substances in the Darknet Markets nowadays.